At the summit, Mr. Mao Hua analyzed the overall landscape of the digital health industry ecosystem and pointed out that with the increasing penetration rate of digital healthcare, continuous deepening of technological innovation in the digital health field, frequent favorable policies for internet-based healthcare, and a significant improvement in residents' health awareness, online hospital services, digitization of offline pharmacies, and the digital upgrade of the entire medical and health industry chain are the core driving forces of the digital health market.
He stated that digital big health is an emerging industry with huge market potential in China. In the past, the penetration rate of digital big health in China's health industry was very low. However, as residents' disposable income continues to increase, people's awareness of health is also constantly improving. As an effective technical means to improve the diagnosis and treatment rate of chronic diseases, digitization is expected to drive growth in the pharmaceutical and medical service markets from the demand side. With the development of digital technology, various service providers on the digital big health industry chain redefine the standards of health and medical practice by providing convenient and efficient healthcare services, helping more patients access high-quality medical resources, realizing valuable health information sharing and communication between hospitals and doctors at all levels, and making digital big health an important part of China's health industry.
He believes that the introduction of a series of policies has emphasized the importance of digital health and defined the blueprint for market development. Previously, the state issued the 'Opinions on Promoting the Development of 'Internet + Healthcare', proposing a series of policy measures to promote the in-depth integration and development of the internet with healthcare. Driven by these policies, hospitals at all levels are actively building internet hospitals, realizing the extension of internet services outside the hospital walls, and accelerating the construction of digital medical infrastructure. 'In 2020, under the impact of the COVID-19 pandemic, digital health played an important role in maintaining necessary medical services through the internet, which also brought about fundamental changes in the behavior patterns of governments, medical institutions, doctors, and patients. This accelerated the popularization rate of digital medical services and promoted the development of the digital health market.'
In addition, he emphasized that technological progress will greatly transform the traditional healthcare service industry. Artificial intelligence and big data support hierarchical diagnostic systems, while the Internet of Things (IoT) and 5G are innovating health management methods in monitoring, prevention, diagnosis, and prognosis management. Stakeholders, including pharmaceutical companies and healthcare institutions, are gradually increasing their demand for related digital infrastructure construction, accelerating the transition to online services.
He believes that driven by technological development and a series of favorable policies, the digital big health industry is expected to see rapid development in the future, with bright prospects.
As a globally renowned growth consulting firm, Frost & Sullivan integrates nearly 60 years of global consulting experience. For 23 years, it has dedicated itself to serving the booming Chinese market and has made the health industry one of its core research areas. Over the past sixteen years, the Frost & Sullivan healthcare team has provided financing, financial advisory, IPO industry advisory, technical advisory, strategic advisory, management advisory services for hundreds of outstanding domestic and international biopharmaceuticals, medical devices, healthcare services, and internet healthcare enterprises. It is a leader and witness in the development of China's pharmaceutical industry. In terms of the number of completed transaction projects, the Frost & Sullivan healthcare team maintains an absolute leading position in Hong Kong healthcare IPOs, continuously occupying more than 90% of the market share from 2018 to 2020. In the future, Frost & Sullivan will continue to explore cutting-edge industry opportunities and work together with enterprises to boost the innovation and upgrading of China's health industry.
